Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program.
Tom Turi, Ph.D.
Chief Scientific Officer at Flagship Biosciences
Friday, September 8 at 12:30 pm
Enabling Precision Medicine Through Digital Pathology
- Expanding the repertoire of biomarkers for patient stratification
- Implementing digital pathology as an integral component of clinical trials
- Validation of digital pathology solutions
Join Flagship CSO, Tom Turi, and other industry experts at the 13th Annual World Clinical Biomarkers & CDx Summit to address critical challenges and discover insights. Across 2 days, 50+ world-class industry stakeholders will address the most critical challenges in Biomarker Discovery & Translational Development, Clinical Biomarker Development, and CDx Development & Commercialization.
Interested in Partnering with Us?
Validated Assays for Use in Immunotherapy Research & Development.
- Customizable options optimized to your needs and validation requirements
- Ability to create multiplex assays to characterize complex cellular interactions
Tailored Companion Diagnostics solutions to meet your research needs
- Valuable insights that can inform clinical decisions and support drug development programs
- Expertise in developing assays for oncology, immune-oncology, neuromuscular disorders, and cell & gene therapies for rare diseases
- Preliminary research, tissue biomarker assay optimization, and assay validation
Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications
- Expertise in novel biomarker and tissue analyses
- Regulatory strategy and support
- Consult with scientific experts
Driving Your Biomarker Strategy: Facts by numbers
- View our resume and history to learn why Flagship is the premier partner for your study
- See the full list of spatial biology services that empower confident clinical decision making
- See the benefits with a fully integrated team of scientists and pathologists